齐齐哈尔医学院学报
齊齊哈爾醫學院學報
제제합이의학원학보
JOURNAL OF QIQIHAR MEDICAL COLLEGE
2015年
10期
1465-1466
,共2页
冠心病快速心律失常%胺碘酮%普罗帕酮%临床治疗
冠心病快速心律失常%胺碘酮%普囉帕酮%臨床治療
관심병쾌속심률실상%알전동%보라파동%림상치료
Coronary heart disease arrhythmia%Amiodarone%Propafenone%Clinical treatment
目的:探讨胺碘酮在急诊冠心病快速心律失常中的有效性及可行性。方法选取2013年1月至2014年2月期间入住我院的78例冠心病快速心率失常患者并将这些患者随机分为对照组和治疗组两组。对这两组施以常规治疗。对对照组使用普罗帕酮进行治疗,对治疗组使用胺碘酮进行治疗。对两组的治疗结果进行比较。结果治疗组39例,显效28例,有效8例,无效3例;对照组39例,显效13例,有效15例,无效11例。在治疗效果上两组患者具有显著的差异P<0.05,这两组数据比较差异经检验具有统计学意义。结论在急诊冠心病快速心律失常的治疗中采用胺碘酮进行治疗,治疗效果显著且明显优于采用普罗帕酮进行治疗。
目的:探討胺碘酮在急診冠心病快速心律失常中的有效性及可行性。方法選取2013年1月至2014年2月期間入住我院的78例冠心病快速心率失常患者併將這些患者隨機分為對照組和治療組兩組。對這兩組施以常規治療。對對照組使用普囉帕酮進行治療,對治療組使用胺碘酮進行治療。對兩組的治療結果進行比較。結果治療組39例,顯效28例,有效8例,無效3例;對照組39例,顯效13例,有效15例,無效11例。在治療效果上兩組患者具有顯著的差異P<0.05,這兩組數據比較差異經檢驗具有統計學意義。結論在急診冠心病快速心律失常的治療中採用胺碘酮進行治療,治療效果顯著且明顯優于採用普囉帕酮進行治療。
목적:탐토알전동재급진관심병쾌속심률실상중적유효성급가행성。방법선취2013년1월지2014년2월기간입주아원적78례관심병쾌속심솔실상환자병장저사환자수궤분위대조조화치료조량조。대저량조시이상규치료。대대조조사용보라파동진행치료,대치료조사용알전동진행치료。대량조적치료결과진행비교。결과치료조39례,현효28례,유효8례,무효3례;대조조39례,현효13례,유효15례,무효11례。재치료효과상량조환자구유현저적차이P<0.05,저량조수거비교차이경검험구유통계학의의。결론재급진관심병쾌속심률실상적치료중채용알전동진행치료,치료효과현저차명현우우채용보라파동진행치료。
Objective To investigate the validity and feasibility of the amiodarone in emergency coronary heart disease arrhythmia.Methods 78 cases of coronary heart disease patients from 2013 January rapid arrhythmia during February to 2014 in our hospital and the patients were randomly divided into treatment group and control group two groups.The two group was treated with conventional therapy.Propafenone treatment, the control group was treated with amiodarone, treatment group.On the treatment of the two groups were compared. Results The treatment group of 39 cases, 28 cases markedly effective, effective 8 cases, invalid in 3 cases;39 cases in the control group, 13 cases markedly effective, effective 15 cases, invalid in 11 cases.The curative effect of the patients in the two groups had significant difference.P<0.05, the two sets of data through the test with statistical significance difference comparison.Conclusions In the treatment of emergency coronary heart disease tachyarrhythmia by amiodarone for the treatment, the treatment effect is significant and is obviously better than using propafenone treatment, it is worth widely promoted in clinical practice.